(VIANEWS) – Shares of BIOSENIC (BEL 20: BIOS.BR) jumped by a staggering 31.58% in 21 sessions from €0.11 to €0.15 at 22:09 EST on Thursday, following the last session’s downward trend. BEL 20 is sliding 0.69% to €3,822.72, after three consecutive sessions in a row of losses.
About BIOSENIC
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
Volatility
BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was 1.77%, 1.93%, and 5.96%.
BIOSENIC’s highest amplitude of average volatility was 4.43% (last week), 10.76% (last month), and 5.96% (last quarter).
More news about BIOSENIC (BIOS.BR).
